CDK2 positively regulates aerobic glycolysis by suppressing SIRT5 in gastric cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CDK2 positively regulates aerobic glycolysis by suppressing SIRT5 in gastric cancer
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-06-13
DOI
10.1111/cas.13691
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Desuccinylation of pyruvate kinase M2 by SIRT5 contributes to antioxidant response and tumor growth
- (2016) Ye Xiangyun et al. Oncotarget
- miR-302b regulates cell cycles by targeting CDK2 via ERK signaling pathway in gastric cancer
- (2016) Fu-Yun Liu et al. Cancer Medicine
- The history and future of targeting cyclin-dependent kinases in cancer therapy
- (2015) Uzma Asghar et al. NATURE REVIEWS DRUG DISCOVERY
- MYC, Metabolism, and Cancer
- (2015) Z. E. Stine et al. Cancer Discovery
- Targeting CDK4 and CDK6: From Discovery to Therapy
- (2015) C. J. Sherr et al. Cancer Discovery
- Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy
- (2014) Stefano Fais et al. CANCER AND METASTASIS REVIEWS
- Gastric cancer: Prevention, screening and early diagnosis
- (2014) Victor Pasechnikov WORLD JOURNAL OF GASTROENTEROLOGY
- SIRT5 desuccinylates and activates SOD1 to eliminate ROS
- (2013) Zhi-Feng Lin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SIRT4 Has Tumor-Suppressive Activity and Regulates the Cellular Metabolic Response to DNA Damage by Inhibiting Mitochondrial Glutamine Metabolism
- (2013) Seung Min Jeong et al. CANCER CELL
- The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4
- (2013) Alfred Csibi et al. CELL
- To be, or not to be
- (2013) Shang-Jui Wang et al. CURRENT OPINION IN ONCOLOGY
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- Targeting Cancer Metabolism
- (2012) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Targeting the p53 signaling pathway in cancer therapy – the promises, challenges and perils
- (2012) Alexander H Stegh EXPERT OPINION ON THERAPEUTIC TARGETS
- Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy
- (2012) Patrick J. Roberts et al. JNCI-Journal of the National Cancer Institute
- Sirtuins as regulators of metabolism and healthspan
- (2012) Riekelt H. Houtkooper et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Emerging roles of PKM2 in cell metabolism and cancer progression
- (2012) Weibo Luo et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
- (2011) Sophia Y. Lunt et al. Annual Review of Cell and Developmental Biology
- SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization
- (2011) Lydia W.S. Finley et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The role of p53 in cell metabolism
- (2010) Xing-ding Zhang et al. ACTA PHARMACOLOGICA SINICA
- Mitochondrial sirtuins
- (2010) Jing-Yi Huang et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation
- (2009) P. Hydbring et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A dual role of Cdk2 in DNA damage response
- (2009) Ande Satyanarayana et al. Cell Division
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started